Supply chain resilience has moved into the deal room

Supply chain resilience

The EU Critical Medicines Act is accelerating a shift in how life sciences organisations assess risk, value and opportunity. Supply chain resilience is no longer just an operational concern. It is increasingly shaping due diligence, valuation and strategic decision-making